190 related articles for article (PubMed ID: 16024783)
1. Convergent actions of I kappa B kinase beta and protein kinase C delta modulate mRNA stability through phosphorylation of 14-3-3 beta complexed with tristetraprolin.
Gringhuis SI; García-Vallejo JJ; van Het Hof B; van Dijk W
Mol Cell Biol; 2005 Aug; 25(15):6454-63. PubMed ID: 16024783
[TBL] [Abstract][Full Text] [Related]
2. Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function.
Rigby WF; Roy K; Collins J; Rigby S; Connolly JE; Bloch DB; Brooks SA
J Immunol; 2005 Jun; 174(12):7883-93. PubMed ID: 15944294
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability.
Mahtani KR; Brook M; Dean JL; Sully G; Saklatvala J; Clark AR
Mol Cell Biol; 2001 Oct; 21(19):6461-9. PubMed ID: 11533235
[TBL] [Abstract][Full Text] [Related]
5. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment.
Marchese FP; Aubareda A; Tudor C; Saklatvala J; Clark AR; Dean JL
J Biol Chem; 2010 Sep; 285(36):27590-600. PubMed ID: 20595389
[TBL] [Abstract][Full Text] [Related]
6. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.
Stoecklin G; Stubbs T; Kedersha N; Wax S; Rigby WF; Blackwell TK; Anderson P
EMBO J; 2004 Mar; 23(6):1313-24. PubMed ID: 15014438
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.
Clement SL; Scheckel C; Stoecklin G; Lykke-Andersen J
Mol Cell Biol; 2011 Jan; 31(2):256-66. PubMed ID: 21078877
[TBL] [Abstract][Full Text] [Related]
8. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway.
Brooks SA; Connolly JE; Rigby WF
J Immunol; 2004 Jun; 172(12):7263-71. PubMed ID: 15187101
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications.
Cao H
Biochemistry; 2004 Nov; 43(43):13724-38. PubMed ID: 15504035
[TBL] [Abstract][Full Text] [Related]
10. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.
Sun L; Stoecklin G; Van Way S; Hinkovska-Galcheva V; Guo RF; Anderson P; Shanley TP
J Biol Chem; 2007 Feb; 282(6):3766-77. PubMed ID: 17170118
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases.
Cao H; Dzineku F; Blackshear PJ
Arch Biochem Biophys; 2003 Apr; 412(1):106-20. PubMed ID: 12646273
[TBL] [Abstract][Full Text] [Related]
12. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding.
Chrestensen CA; Schroeder MJ; Shabanowitz J; Hunt DF; Pelo JW; Worthington MT; Sturgill TW
J Biol Chem; 2004 Mar; 279(11):10176-84. PubMed ID: 14688255
[TBL] [Abstract][Full Text] [Related]
13. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
Deleault KM; Skinner SJ; Brooks SA
Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
[TBL] [Abstract][Full Text] [Related]
14. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.
Ogilvie RL; Abelson M; Hau HH; Vlasova I; Blackshear PJ; Bohjanen PR
J Immunol; 2005 Jan; 174(2):953-61. PubMed ID: 15634918
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
Leppänen T; Jalonen U; Korhonen R; Tuominen RK; Moilanen E
Eur J Pharmacol; 2010 Feb; 628(1-3):220-5. PubMed ID: 19925787
[TBL] [Abstract][Full Text] [Related]
16. Control of mRNA decay by phosphorylation of tristetraprolin.
Sandler H; Stoecklin G
Biochem Soc Trans; 2008 Jun; 36(Pt 3):491-6. PubMed ID: 18481987
[TBL] [Abstract][Full Text] [Related]
17. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling.
Marderosian M; Sharma A; Funk AP; Vartanian R; Masri J; Jo OD; Gera JF
Oncogene; 2006 Oct; 25(47):6277-90. PubMed ID: 16702957
[TBL] [Abstract][Full Text] [Related]
18. The Conserved CNOT1 Interaction Motif of Tristetraprolin Regulates ARE-mRNA Decay Independently of the p38 MAPK-MK2 Kinase Pathway.
Carreño A; Lykke-Andersen J
Mol Cell Biol; 2022 Sep; 42(9):e0005522. PubMed ID: 35920669
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
Stoecklin G; Gross B; Ming XF; Moroni C
Oncogene; 2003 Jun; 22(23):3554-61. PubMed ID: 12789264
[TBL] [Abstract][Full Text] [Related]
20. CNOT7/hCAF1 is involved in ICAM-1 and IL-8 regulation by tristetraprolin.
Shi JX; Li JS; Hu R; Shi Y; Su X; Li Q; Zhang F
Cell Signal; 2014 Nov; 26(11):2390-6. PubMed ID: 25038453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
